Instant Insight
30-Second Take
- USAID funding cuts have severely impacted global tuberculosis control efforts, leading to the closure of TB diagnosis and treatment services.
- The cuts could result in the emergence of drug-resistant TB strains due to interrupted treatment and lack of access to medications.
- These disruptions threaten decades of progress in TB prevention and treatment, particularly in low- and middle-income countries.
+ Dive Deeper
Quick Brief
2-Minute Digest
Essential Context
The recent 90-day funding freeze on foreign aid by the U.S. government, followed by the cancellation of over 90% of USAID contracts, has crippled global tuberculosis (TB) control efforts. USAID, the largest bilateral donor for TB programs, has been a critical component in the fight against TB, especially in low- and middle-income countries.
Core Players
- USAID – Primary agency for U.S. foreign aid, including global health programs.
- World Health Organization (WHO) – Global leader in health policy and coordination.
- Stop TB Partnership – A global nonprofit focused on TB prevention and treatment.
- Lucica Ditiu – Executive Director of the Stop TB Partnership.
Key Numbers
- $406 million – USAID funding for global TB control in 2024.
- $200-$250 million – Annual U.S. bilateral funding for TB programs.
- 58 million – TB patients saved by USAID and its partners since 2000.
- 18 – Number of high-burden countries heavily reliant on U.S. funding for TB care.
- 3,500 – Daily deaths from TB worldwide.
+ Full Analysis
Full Depth
Complete Coverage
The Catalyst
The funding freeze and subsequent contract cancellations were implemented without warning, leaving no part of the global TB control community untouched. This sudden halt has resulted in the closure of TB diagnosis and treatment services, particularly in high-burden countries.
“Any disruption to TB services—whether financial, political, or operational—can have devastating and often fatal consequences for millions worldwide,” said Dr. Tereza Kasaeva, Director of WHO’s Global Programme on TB and Lung Health.
Inside Forces
The cuts have disrupted the entire TB ecosystem, including drug distribution, laboratory services, and community engagement efforts. TB medications are not being distributed due to unpaid USAID-funded workers, and clinical trials involving new drug regimens and TB research have been halted.
Lucica Ditiu of the Stop TB Partnership emphasized that the loss of U.S. funding will force organizations to downsize and seek alternative funding sources, potentially from international competitors like China.
Power Dynamics
The U.S. government, through USAID, has been the largest bilateral donor for TB programs. The sudden withdrawal of this funding has shifted the power dynamics, leaving global health organizations and low- and middle-income countries scrambling to find alternative funding sources.
The State Department’s claim that life-saving treatments for diseases like TB have been spared has been disputed by key stakeholders, including Lucica Ditiu, who stated that her organization has lost funding despite the claims.
Outside Impact
The broader implications of these funding cuts are severe. The interruption in TB services could lead to the emergence of drug-resistant TB strains, which would be catastrophic for global health. This is particularly concerning because TB is an airborne disease, making it difficult to contain once it spreads.
“TB is airborne. You can wear a condom, you can sleep under a bed net, you can run and exercise and eat just kale all your life. As long as you breathe, you can get TB,” Ditiu warned.
Future Forces
The immediate future looks grim for TB control efforts. Without swift and strategic action to restore funding, the progress made over the past two decades could be reversed. The WHO and other global health organizations are urging immediate intervention to protect the most vulnerable populations and maintain momentum toward ending TB.
Long-term, the global community may need to rely more heavily on other donors and innovative funding mechanisms to sustain TB prevention and treatment programs.
Data Points
- January 2025: 90-day funding freeze on foreign aid implemented.
- February 2025: Over 90% of USAID contracts canceled.
- 2000-2024: USAID and its partners saved over 58 million TB patients.
- 2020-2023: Over 700,000 excess deaths from TB due to COVID-19-related service interruptions.
- 2027 and 2030: Target years for achieving End TB targets set by WHO.
The abrupt cuts in USAID funding have thrown the global fight against tuberculosis into chaos. As the world grapples with the consequences, it is clear that immediate and sustained action is necessary to prevent a catastrophic setback in TB control efforts.
